Market Value1,081,089,000
Total Holdings64
File Date2020-05-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
US62857M1053 / MyoKardia, Inc.
ETTX / Entasis Therapeutics Holdings Inc
ITRM / Iterum Therapeutics plc
US0153511094 / Alexion Pharmaceuticals, Inc.
APLT / Applied Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
ZGNX / Zogenix Inc
AGTC / Applied Genetic Technologies Corp
MRSN / Mersana Therapeutics, Inc.
CGEN / Compugen Ltd.
IOVA / Iovance Biotherapeutics, Inc. Call
ABBV / AbbVie Inc.
FOLD / Amicus Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
FOMX / Foamix Pharmaceuticals Ltd.
MDCO / Medicines Company Put
XBIT / XBiotech Inc.
DERM / Journey Medical Corporation
PBYI / Puma Biotechnology, Inc.
KDMN / Kadmon Holdings Inc
US74257L1089 / Principia Biopharma Inc.
BIIB / Biogen Inc.
FTSV / Forty Seven, Inc.
HALO / Halozyme Therapeutics, Inc.
US16706W1027 / Chiasma Inc
MGNX / MacroGenics, Inc.
VYNE / VYNE Therapeutics Inc.
FIXX / Homology Medicines, Inc.
ARQL / ArQule, Inc.
DRNA / Dicerna Pharmaceuticals Inc
MRUS / Merus N.V.
OTIC / Otonomy Inc
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
BMRN / BioMarin Pharmaceutical Inc.
REGN / Regeneron Pharmaceuticals, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
APLS / Apellis Pharmaceuticals, Inc.
XLRN / Acceleron Pharma Inc
US0153511094 / Alexion Pharmaceuticals, Inc. Call
CALA / Calithera Biosciences, Inc.
ZYME / Zymeworks Inc.
FATE / Fate Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc.
CCXI / ChemoCentryx Inc
SGEN / Seagen Inc
HRTX / Heron Therapeutics, Inc.
CHRS / Coherus Oncology, Inc.
KALA / KALA BIO, Inc. Put
KALA / KALA BIO, Inc.
AKRO / Akero Therapeutics, Inc. Put
OBSV / ObsEva SA.
VRTX / Vertex Pharmaceuticals Incorporated
MIRM / Mirum Pharmaceuticals, Inc.
ALGN / Align Technology, Inc.
MRTX / Mirati Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
14161H108 / Cardtronics PLC
MRK / Merck & Co., Inc.
GRTX / Galera Therapeutics, Inc.
PTCT / PTC Therapeutics, Inc.
KRTX / Karuna Therapeutics, Inc.
SYBX / Synlogic, Inc.
UTHR / United Therapeutics Corporation
RIGL / Rigel Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
NXTC / NextCure, Inc.
NCNA / NuCana plc - Depositary Receipt (Common Stock)
SRPT / Sarepta Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
AXSM / Axsome Therapeutics, Inc.
PTCT / PTC Therapeutics, Inc. Call
RYTM / Rhythm Pharmaceuticals, Inc.
GILD / Gilead Sciences, Inc. Call
NTRA / Natera, Inc.
TGTX / TG Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc. Call
YMAB / Y-mAbs Therapeutics, Inc.
PDSB / PDS Biotechnology Corporation